Impact of Omicron Variant Infection on Female Fertility and Laboratory Outcomes: A Self‐Controlled Study
Our study suggested that undergoing IVF/ICSI treatment after recovering from COVID-19 may not adversely affect female fertility and laboratory outcomes.
Authors
- Yubin Ding (ORCID: https://orcid.org/0000-0002-7870-9445)
- Hongjiang Xu (ORCID: https://orcid.org/0009-0008-1626-4867)
- Xing-yu Lv
- Meihua Bao (ORCID: https://orcid.org/0000-0003-4784-7076)
- Zhaoyang Zhong (ORCID: https://orcid.org/0000-0002-2338-038X)
- Simon C.H. Yu (ORCID: https://orcid.org/0000-0002-8715-5026)
- Lijuan Fu (ORCID: https://orcid.org/0000-0003-4890-9304)
- R. Liu
- Y Zhang
- Li Geng (ORCID: https://orcid.org/0000-0001-6221-4846)
- Yu‐Ling Hu
Institutions
- Changsha Medical University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- American Journal of Reproductive Immunology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1111/aji.70012
- Citations
- 14
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 8.16
Funders
- National Key Research and Development Program of China